PL3732165T3 - Pochodne peptydowe i ich aktywność terapeutyczna - Google Patents

Pochodne peptydowe i ich aktywność terapeutyczna

Info

Publication number
PL3732165T3
PL3732165T3 PL18836407.9T PL18836407T PL3732165T3 PL 3732165 T3 PL3732165 T3 PL 3732165T3 PL 18836407 T PL18836407 T PL 18836407T PL 3732165 T3 PL3732165 T3 PL 3732165T3
Authority
PL
Poland
Prior art keywords
therapeutic activity
peptide derivatives
peptide
derivatives
therapeutic
Prior art date
Application number
PL18836407.9T
Other languages
English (en)
Inventor
Gianpaolo Negrisoli
Stefania Gagliardi
Almin SILNOVIC
Clelia Dallanoce
Marco De Amici
Renato Canevotti
Original Assignee
Flamma S.P.A.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Flamma S.P.A. filed Critical Flamma S.P.A.
Publication of PL3732165T3 publication Critical patent/PL3732165T3/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • C07D233/58—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/64—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms, e.g. histidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/12—Ophthalmic agents for cataracts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Diabetes (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Ophthalmology & Optometry (AREA)
  • Hematology (AREA)
  • Hospice & Palliative Care (AREA)
  • Obesity (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
PL18836407.9T 2017-12-27 2018-12-19 Pochodne peptydowe i ich aktywność terapeutyczna PL3732165T3 (pl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT201700149628 2017-12-27
PCT/IB2018/060332 WO2019130164A1 (en) 2017-12-27 2018-12-19 Peptide derivatives and therapeutic activity thereof

Publications (1)

Publication Number Publication Date
PL3732165T3 true PL3732165T3 (pl) 2022-12-05

Family

ID=61873692

Family Applications (1)

Application Number Title Priority Date Filing Date
PL18836407.9T PL3732165T3 (pl) 2017-12-27 2018-12-19 Pochodne peptydowe i ich aktywność terapeutyczna

Country Status (8)

Country Link
US (1) US11420943B2 (pl)
EP (1) EP3732165B1 (pl)
JP (1) JP7217749B2 (pl)
ES (1) ES2927901T3 (pl)
HU (1) HUE060194T2 (pl)
PL (1) PL3732165T3 (pl)
SI (1) SI3732165T1 (pl)
WO (1) WO2019130164A1 (pl)

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1994011012A1 (en) * 1992-11-06 1994-05-26 Merck & Co., Inc. Substituted dipeptide analogs promote release of growth hormone
EP0828754B1 (en) * 1995-05-29 2005-02-02 Pfizer Inc. Dipeptides which promote release of growth hormone
ITMI20061218A1 (it) 2006-06-23 2007-12-24 Flamma Spa Derivati pepticidi e loro attivita' terapeutica
IT1397212B1 (it) 2009-12-29 2013-01-04 Flamma Spa Derivati di amminoalcoli e loro attivita' terapeutica
EP3052556B1 (en) 2013-10-03 2021-01-20 3M Innovative Properties Company Ligand-functionalized substrates with enhanced binding capacity

Also Published As

Publication number Publication date
ES2927901T3 (es) 2022-11-11
WO2019130164A1 (en) 2019-07-04
JP2021509893A (ja) 2021-04-08
EP3732165A1 (en) 2020-11-04
SI3732165T1 (sl) 2022-11-30
US11420943B2 (en) 2022-08-23
JP7217749B2 (ja) 2023-02-03
HUE060194T2 (hu) 2023-02-28
US20200361875A1 (en) 2020-11-19
EP3732165B1 (en) 2022-08-17

Similar Documents

Publication Publication Date Title
IL253712A0 (en) Mysterlein derivatives for coupling and healing
EP3720502A4 (en) CYTOBIOLOGICAL PRODUCTS AND THEIR THERAPEUTIC USES
IL256515A (en) Therapeutic peptides and methods of use thereof
GB201715194D0 (en) Compounds and their therapeutic use
EP3677590A4 (en) PEPTIDE WITH WRINKLE MITIGATION AND ASSOCIATED USES
ZA201905372B (en) Therapeutic and neuroprotective peptides
PL3618848T3 (pl) Biologicznie aktywne kompleksy i ich zastosowania terapeutyczne
IL270011B (en) Medicinal compounds and methods
EP3418292A4 (en) PEPTIDE WITH MELANINE GENERATION ACTIVITY AND USE THEREOF
EP3702362A4 (en) POLYPEPTIDE WITH ANALGETIC ACTIVITY AND USES THEREOF
ZA201902689B (en) Therapeutic protein
IL272050A (en) Synthetic proteins and their therapeutic uses
EP3313427A4 (en) Therapeutic peptides and methods of use thereof
EP3412275A4 (en) PEPTIDE WITH SKIN-LIGHTING ACTIVITY AND USE THEREOF
ZA201904386B (en) S-arrestin peptides and therapeutic uses thereof
HUE062120T2 (hu) Peptid-származék és alkalmazása
GB201700526D0 (en) Therapeutic use
ZA202000959B (en) Adamantylmethylamine derivative and use thereof as pharmaceutical
PT3664800T (pt) Formulações terapêuticas que compreendem inibidor da cox-2 e utilizações das mesmas
HUE060194T2 (hu) Peptid-származékok és azok terápiai hatása
EP3615551A4 (en) MODIFIED CYCLIC PEPTIDES AND THEIR THERAPEUTIC USES
IL282157A (en) Compounds and their medicinal uses
GB201718320D0 (en) Therapeutic substances and their preparation
EP3606561C0 (en) NOVEL COMPOUNDS AND THERAPEUTIC USES THEREOF
GB201802743D0 (en) Medicament and use thereof